Compare Stocks → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CRMDNYSE:IBIONASDAQ:KLDONASDAQ:NEPT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRMDCorMedix$5.28-2.6%$4.01$2.57▼$7.00$289.40M1.86552,732 shs1.99 million shsIBIOiBio$1.71-3.4%$0.00$1.02▼$27.80$5.95M-3.513.19 million shs95,243 shsKLDOKaleido Biosciences$0.00$0.00▼$0.03$4K-0.064,361 shs935 shsNEPTNeptune Wellness Solutions$0.39$0.19▼$28.00$906K2.19462,687 shs2.25 million shs(Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRMDCorMedix-0.37%-15.18%+41.51%+66.26%+12.33%IBIOiBio-5.85%-11.50%+40.48%+176,999,900.00%+176,999,900.00%KLDOKaleido Biosciences0.00%0.00%0.00%0.00%-50.00%NEPTNeptune Wellness Solutions0.00%0.00%0.00%-59.18%-99.22%Secret Bull Market Starts in This Unusual Sector (Ad)"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRMDCorMedix1.4244 of 5 stars3.50.00.00.03.01.70.6IBIOiBioN/AN/AN/AN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRMDCorMedix3.00Buy$13.00146.21% UpsideIBIOiBioN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/ACurrent Analyst RatingsLatest KLDO, CRMD, NEPT, and IBIO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/9/2024CRMDCorMedixJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$19.004/9/2024CRMDCorMedixNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.003/13/2024CRMDCorMedixRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$10.00 ➝ $9.001/31/2024CRMDCorMedixTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$18.00 ➝ $14.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRMDCorMedix$60K4,823.28N/AN/A$1.28 per share4.13IBIOiBio$2.38M2.50N/AN/A$15.15 per share0.11KLDOKaleido Biosciences$1.10M0.00N/AN/AN/ANaNNEPTNeptune Wellness Solutions$52.62M0.00N/AN/A($91.90) per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRMDCorMedix-$46.34M-$0.92N/AN/AN/AN/A-72.31%-63.97%5/20/2024 (Estimated)IBIOiBio-$65.01MN/A0.00∞N/AN/A-150.59%-52.83%N/AKLDOKaleido BiosciencesN/A-$2.24N/AN/AN/AN/AN/AN/AN/ANEPTNeptune Wellness Solutions-$60.46M-$106.72N/AN/AN/A-128.13%N/A-141.94%7/15/2024 (Estimated)Latest KLDO, CRMD, NEPT, and IBIO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/12/2024Q4 2023CRMDCorMedix-$0.21-$0.26-$0.05-$0.26N/AN/A2/9/2024Q2 2024IBIOiBioN/A-$2.42-$2.42-$0.42N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRMDCorMedixN/AN/AN/AN/AN/AIBIOiBioN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRMDCorMedixN/A6.976.78IBIOiBio0.040.910.91KLDOKaleido BiosciencesN/AN/AN/ANEPTNeptune Wellness SolutionsN/A0.230.10OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRMDCorMedix34.18%IBIOiBio7.90%KLDOKaleido Biosciences81.56%NEPTNeptune Wellness Solutions14.44%Insider OwnershipCompanyInsider OwnershipCRMDCorMedix3.60%IBIOiBio1.12%KLDOKaleido Biosciences9.00%NEPTNeptune Wellness Solutions5.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCRMDCorMedix8254.81 million52.84 millionOptionableIBIOiBio263.48 million3.45 millionN/AKLDOKaleido Biosciences7642.62 million38.79 millionNot OptionableNEPTNeptune Wellness Solutions584.53 million4.30 millionNot OptionableKLDO, CRMD, NEPT, and IBIO HeadlinesSourceHeadlineNeptune Wellness Solutions (NASDAQ:NEPT) Now Covered by Analysts at StockNews.comamericanbankingnews.com - April 16 at 2:22 AMNeptune prepared to take legal action against property owner of the homeless encampmentmsn.com - April 9 at 2:18 PMCity of Neptune Beach unveils new water tower designmsn.com - April 7 at 1:48 PMGunbattle between Haitian police and gangs paralyzes area near National Palacesaratogian.com - April 2 at 1:45 AMThe Wellness Innovation Summit at the Knoxville Convention Center Saturday, April 6thwate.com - April 1 at 10:44 AMSNAPSHOT: Construction supervisor credits BOCES with building him a solid foundation for his futuresaratogian.com - April 1 at 10:44 AMWellness Wednesday – Focusing on Cardiovascular Healthnwahomepage.com - March 28 at 6:30 PMFood Encapsulation Market Industry Chain Information, Emerging Market Regions (2024-2032)taiwannews.com.tw - March 28 at 6:30 PMSNAPSHOT: The Bunker celebrates opening of newest location in Saratoga Springssaratogian.com - March 25 at 8:40 AMSNAPSHOT: Capital Region BOCES event will link students to employers and recruiterssaratogian.com - March 24 at 9:05 AMKingdom Wellness & Dispensary opens new retail locationwestsidenewsny.com - March 18 at 12:39 PMWellness expo promotes better health within Black familiesksdk.com - March 17 at 8:17 PMRooted Wellness celebrates grand openinglowellsun.com - March 15 at 8:16 PMClinton to host Mayor's Wellness Program on Saturday, March 23newjerseyhills.com - March 15 at 3:15 PMYour Weekly Horoscopes: March 17 to 23, 2024purewow.com - March 15 at 12:13 AMHealthwise Wellness hosts clinic open housearkansasonline.com - March 13 at 7:38 AMSouthwell Center for Healing and Wellness to permanently closemsn.com - March 12 at 12:26 AMNeptune Software: 'Environmental Supply Chains - You Don't Need to Sacrifice Profitability to Act Sustainably'tmcnet.com - March 11 at 2:25 PMNeptune Wellness Solutions Inc.wsj.com - March 9 at 8:59 AMNeptune Wellness appoints Michael De Geus as interim president, CEOmsn.com - March 8 at 9:40 AMNeptune Appoints Interim President and CEO and Interim COOaccesswire.com - March 8 at 8:30 AMNeptune Wellness to be delisted from Nasdaqinvesting.com - March 8 at 12:42 AMTop Marijuana Stocks For Trading Today 2024marijuanastocks.com - March 6 at 9:06 AMNeptune Announces Decision of Nasdaq Hearings Panel To Delist Common Sharesaccesswire.com - March 6 at 8:30 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsCorMedixNASDAQ:CRMDCorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.iBioNYSE:IBIOiBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel. The company is also developing vaccine candidates, including IBIO-101, an antibody to reduce tumor growth; Endostatin E4 peptide for use in chemotherapy and immunotherapy; Trop-2 for the treatment Trop-2 positive cancers; MUC16, a tumor-associated epitope; anti-EGFRvIII antibody to treat glioblastoma and other cancers; CCR8 protein candidate for treatment of various cancers; PD-1 agonist for the treatment of rheumatoid arthritis and other inflammatory diseases; and IBIO-400 for the treatment of classical swine fever. iBio, Inc. has agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; and a research collaboration with the National Institute of Allergy and Infectious Diseases to investigate the potential of the company's AI-driven epitope steering platform for the development of a vaccine for Lassa fever. The company was incorporated in 2008 and is headquartered in Bryan, Texas.Kaleido BiosciencesNASDAQ:KLDOKaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.Neptune Wellness SolutionsNASDAQ:NEPTNeptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.